nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Thalidomide—leprosy	0.174	0.355	CbGbCtD
Maprotiline—CYP1A2—Rifampicin—leprosy	0.168	0.344	CbGbCtD
Maprotiline—ABCB1—Rifampicin—leprosy	0.147	0.301	CbGbCtD
Maprotiline—HRH1—nose—leprosy	0.0192	0.0886	CbGeAlD
Maprotiline—CHRM5—skin epidermis—leprosy	0.0162	0.075	CbGeAlD
Maprotiline—HTR7—cranial nerve—leprosy	0.0144	0.0664	CbGeAlD
Maprotiline—HTR2A—trigeminal nerve—leprosy	0.0126	0.0581	CbGeAlD
Maprotiline—SLC6A3—nerve—leprosy	0.00948	0.0438	CbGeAlD
Maprotiline—HTR7—peripheral nervous system—leprosy	0.00945	0.0436	CbGeAlD
Maprotiline—HTR2A—cranial nerve—leprosy	0.00897	0.0414	CbGeAlD
Maprotiline—Tongue discolouration—Thalidomide—leprosy	0.00854	0.0291	CcSEcCtD
Maprotiline—SLC6A2—nerve—leprosy	0.00765	0.0353	CbGeAlD
Maprotiline—HTR2A—hindlimb—leprosy	0.00756	0.0349	CbGeAlD
Maprotiline—HTR7—nerve—leprosy	0.00737	0.034	CbGeAlD
Maprotiline—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.0071	0.0242	CcSEcCtD
Maprotiline—DRD2—nerve—leprosy	0.00697	0.0322	CbGeAlD
Maprotiline—HTR2A—appendage—leprosy	0.00648	0.0299	CbGeAlD
Maprotiline—Galactorrhoea—Thalidomide—leprosy	0.00637	0.0217	CcSEcCtD
Maprotiline—HTR2A—peripheral nervous system—leprosy	0.00589	0.0272	CbGeAlD
Maprotiline—Interstitial lung disease—Thalidomide—leprosy	0.00583	0.0199	CcSEcCtD
Maprotiline—HTR7—blood vessel—leprosy	0.00579	0.0267	CbGeAlD
Maprotiline—CHRM5—eye—leprosy	0.00579	0.0267	CbGeAlD
Maprotiline—Psychotic disorder—Dapsone—leprosy	0.00572	0.0195	CcSEcCtD
Maprotiline—Muscular weakness—Dapsone—leprosy	0.00516	0.0176	CcSEcCtD
Maprotiline—Tingling sensation—Thalidomide—leprosy	0.00514	0.0175	CcSEcCtD
Maprotiline—CHRM5—skin of body—leprosy	0.00503	0.0232	CbGeAlD
Maprotiline—Petechiae—Thalidomide—leprosy	0.00502	0.0171	CcSEcCtD
Maprotiline—Numbness—Thalidomide—leprosy	0.00498	0.017	CcSEcCtD
Maprotiline—Endocrine disorder—Thalidomide—leprosy	0.00498	0.017	CcSEcCtD
Maprotiline—Sensory loss—Thalidomide—leprosy	0.00477	0.0162	CcSEcCtD
Maprotiline—Photosensitivity reaction—Dapsone—leprosy	0.00462	0.0157	CcSEcCtD
Maprotiline—HTR2A—nerve—leprosy	0.0046	0.0212	CbGeAlD
Maprotiline—Bone disorder—Thalidomide—leprosy	0.00457	0.0156	CcSEcCtD
Maprotiline—Neuropathy peripheral—Dapsone—leprosy	0.00442	0.0151	CcSEcCtD
Maprotiline—Dyskinesia—Thalidomide—leprosy	0.00439	0.015	CcSEcCtD
Maprotiline—Atrioventricular block—Thalidomide—leprosy	0.00426	0.0145	CcSEcCtD
Maprotiline—Coordination abnormal—Thalidomide—leprosy	0.0042	0.0143	CcSEcCtD
Maprotiline—CHRM4—testis—leprosy	0.00406	0.0187	CbGeAlD
Maprotiline—CHRM4—nervous system—leprosy	0.00398	0.0184	CbGeAlD
Maprotiline—Tinnitus—Dapsone—leprosy	0.00378	0.0129	CcSEcCtD
Maprotiline—Gynaecomastia—Thalidomide—leprosy	0.00369	0.0126	CcSEcCtD
Maprotiline—HTR2A—blood vessel—leprosy	0.00361	0.0167	CbGeAlD
Maprotiline—Hyperkinesia—Thalidomide—leprosy	0.0036	0.0123	CcSEcCtD
Maprotiline—Vascular purpura—Thalidomide—leprosy	0.00335	0.0114	CcSEcCtD
Maprotiline—Vision blurred—Dapsone—leprosy	0.00332	0.0113	CcSEcCtD
Maprotiline—Libido decreased—Thalidomide—leprosy	0.00323	0.011	CcSEcCtD
Maprotiline—Increased appetite—Thalidomide—leprosy	0.00319	0.0109	CcSEcCtD
Maprotiline—CHRM5—nervous system—leprosy	0.00311	0.0144	CbGeAlD
Maprotiline—Purpura—Thalidomide—leprosy	0.00311	0.0106	CcSEcCtD
Maprotiline—Cerebrovascular accident—Thalidomide—leprosy	0.00306	0.0104	CcSEcCtD
Maprotiline—Osteoarthritis—Thalidomide—leprosy	0.003	0.0102	CcSEcCtD
Maprotiline—Disturbance in sexual arousal—Thalidomide—leprosy	0.00297	0.0101	CcSEcCtD
Maprotiline—Psychotic disorder—Thalidomide—leprosy	0.00293	0.00997	CcSEcCtD
Maprotiline—DRD2—eye—leprosy	0.00291	0.0134	CbGeAlD
Maprotiline—Ataxia—Thalidomide—leprosy	0.00282	0.0096	CcSEcCtD
Maprotiline—Tachycardia—Dapsone—leprosy	0.00281	0.00957	CcSEcCtD
Maprotiline—Liver function test abnormal—Thalidomide—leprosy	0.00277	0.00943	CcSEcCtD
Maprotiline—Orthostatic hypotension—Thalidomide—leprosy	0.00274	0.00933	CcSEcCtD
Maprotiline—Breast disorder—Thalidomide—leprosy	0.00271	0.00923	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Thalidomide—leprosy	0.0027	0.00919	CcSEcCtD
Maprotiline—Muscular weakness—Thalidomide—leprosy	0.00264	0.00901	CcSEcCtD
Maprotiline—Insomnia—Dapsone—leprosy	0.0026	0.00887	CcSEcCtD
Maprotiline—Dysphagia—Thalidomide—leprosy	0.00259	0.00883	CcSEcCtD
Maprotiline—Eosinophilia—Thalidomide—leprosy	0.00256	0.00874	CcSEcCtD
Maprotiline—Bronchospasm—Thalidomide—leprosy	0.00255	0.00868	CcSEcCtD
Maprotiline—Pancytopenia—Thalidomide—leprosy	0.00246	0.00838	CcSEcCtD
Maprotiline—Pollakiuria—Thalidomide—leprosy	0.00239	0.00815	CcSEcCtD
Maprotiline—Erectile dysfunction—Thalidomide—leprosy	0.00239	0.00813	CcSEcCtD
Maprotiline—ABCB1—blood vessel—leprosy	0.00236	0.0109	CbGeAlD
Maprotiline—Photosensitivity reaction—Thalidomide—leprosy	0.00236	0.00806	CcSEcCtD
Maprotiline—Weight increased—Thalidomide—leprosy	0.00236	0.00803	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dapsone—leprosy	0.00235	0.00802	CcSEcCtD
Maprotiline—Weight decreased—Thalidomide—leprosy	0.00234	0.00798	CcSEcCtD
Maprotiline—Drowsiness—Thalidomide—leprosy	0.00231	0.00787	CcSEcCtD
Maprotiline—Infestation—Thalidomide—leprosy	0.00231	0.00787	CcSEcCtD
Maprotiline—Infestation NOS—Thalidomide—leprosy	0.00231	0.00787	CcSEcCtD
Maprotiline—HRH1—eye—leprosy	0.0023	0.0106	CbGeAlD
Maprotiline—ORM1—nervous system—leprosy	0.00229	0.0106	CbGeAlD
Maprotiline—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00229	0.0078	CcSEcCtD
Maprotiline—Acute coronary syndrome—Thalidomide—leprosy	0.00228	0.00776	CcSEcCtD
Maprotiline—Body temperature increased—Dapsone—leprosy	0.00227	0.00775	CcSEcCtD
Maprotiline—Abdominal pain—Dapsone—leprosy	0.00227	0.00775	CcSEcCtD
Maprotiline—Myocardial infarction—Thalidomide—leprosy	0.00226	0.00771	CcSEcCtD
Maprotiline—Neuropathy peripheral—Thalidomide—leprosy	0.00226	0.00771	CcSEcCtD
Maprotiline—Stomatitis—Thalidomide—leprosy	0.00225	0.00767	CcSEcCtD
Maprotiline—SLC6A3—testis—leprosy	0.00217	0.01	CbGeAlD
Maprotiline—Agranulocytosis—Thalidomide—leprosy	0.00216	0.00734	CcSEcCtD
Maprotiline—CHRM2—nervous system—leprosy	0.00214	0.00987	CbGeAlD
Maprotiline—SLC6A3—nervous system—leprosy	0.00213	0.00984	CbGeAlD
Maprotiline—Hepatitis—Thalidomide—leprosy	0.00207	0.00706	CcSEcCtD
Maprotiline—Hypoaesthesia—Thalidomide—leprosy	0.00206	0.00703	CcSEcCtD
Maprotiline—HTR2C—nervous system—leprosy	0.00206	0.00951	CbGeAlD
Maprotiline—Urinary tract disorder—Thalidomide—leprosy	0.00205	0.00698	CcSEcCtD
Maprotiline—HTR7—tendon—leprosy	0.00204	0.00942	CbGeAlD
Maprotiline—Urethral disorder—Thalidomide—leprosy	0.00203	0.00692	CcSEcCtD
Maprotiline—Erythema multiforme—Thalidomide—leprosy	0.00196	0.00668	CcSEcCtD
Maprotiline—CHRM1—nervous system—leprosy	0.00195	0.00898	CbGeAlD
Maprotiline—Eye disorder—Thalidomide—leprosy	0.00194	0.0066	CcSEcCtD
Maprotiline—Tinnitus—Thalidomide—leprosy	0.00193	0.00659	CcSEcCtD
Maprotiline—Cardiac disorder—Thalidomide—leprosy	0.00192	0.00656	CcSEcCtD
Maprotiline—HTR2A—eye—leprosy	0.00192	0.00887	CbGeAlD
Maprotiline—Angiopathy—Thalidomide—leprosy	0.00188	0.00641	CcSEcCtD
Maprotiline—Mediastinal disorder—Thalidomide—leprosy	0.00187	0.00637	CcSEcCtD
Maprotiline—Arrhythmia—Thalidomide—leprosy	0.00185	0.00631	CcSEcCtD
Maprotiline—Alopecia—Thalidomide—leprosy	0.00183	0.00624	CcSEcCtD
Maprotiline—Vomiting—Dapsone—leprosy	0.00183	0.00623	CcSEcCtD
Maprotiline—Malnutrition—Thalidomide—leprosy	0.0018	0.00615	CcSEcCtD
Maprotiline—Headache—Dapsone—leprosy	0.0018	0.00614	CcSEcCtD
Maprotiline—CHRM3—testis—leprosy	0.00177	0.00819	CbGeAlD
Maprotiline—Tension—Thalidomide—leprosy	0.00177	0.00603	CcSEcCtD
Maprotiline—Dysgeusia—Thalidomide—leprosy	0.00177	0.00602	CcSEcCtD
Maprotiline—Nervousness—Thalidomide—leprosy	0.00175	0.00597	CcSEcCtD
Maprotiline—SLC6A2—testis—leprosy	0.00175	0.00809	CbGeAlD
Maprotiline—CHRM3—nervous system—leprosy	0.00174	0.00804	CbGeAlD
Maprotiline—SLC6A2—nervous system—leprosy	0.00172	0.00794	CbGeAlD
Maprotiline—Nausea—Dapsone—leprosy	0.00171	0.00582	CcSEcCtD
Maprotiline—Vision blurred—Thalidomide—leprosy	0.0017	0.0058	CcSEcCtD
Maprotiline—Tremor—Thalidomide—leprosy	0.00169	0.00576	CcSEcCtD
Maprotiline—HTR7—testis—leprosy	0.00169	0.0078	CbGeAlD
Maprotiline—Agitation—Thalidomide—leprosy	0.00166	0.00565	CcSEcCtD
Maprotiline—HTR7—nervous system—leprosy	0.00166	0.00765	CbGeAlD
Maprotiline—Syncope—Thalidomide—leprosy	0.00162	0.00551	CcSEcCtD
Maprotiline—Leukopenia—Thalidomide—leprosy	0.00162	0.0055	CcSEcCtD
Maprotiline—DRD2—testis—leprosy	0.0016	0.00737	CbGeAlD
Maprotiline—Palpitations—Thalidomide—leprosy	0.0016	0.00543	CcSEcCtD
Maprotiline—Loss of consciousness—Thalidomide—leprosy	0.00159	0.0054	CcSEcCtD
Maprotiline—DRD2—nervous system—leprosy	0.00157	0.00723	CbGeAlD
Maprotiline—Convulsion—Thalidomide—leprosy	0.00156	0.00533	CcSEcCtD
Maprotiline—Hypertension—Thalidomide—leprosy	0.00156	0.00531	CcSEcCtD
Maprotiline—Anxiety—Thalidomide—leprosy	0.00153	0.00522	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00153	0.0052	CcSEcCtD
Maprotiline—HRH1—tendon—leprosy	0.00152	0.00703	CbGeAlD
Maprotiline—Dry mouth—Thalidomide—leprosy	0.0015	0.00512	CcSEcCtD
Maprotiline—Confusional state—Thalidomide—leprosy	0.00149	0.00506	CcSEcCtD
Maprotiline—Oedema—Thalidomide—leprosy	0.00147	0.00502	CcSEcCtD
Maprotiline—Infection—Thalidomide—leprosy	0.00146	0.00499	CcSEcCtD
Maprotiline—Shock—Thalidomide—leprosy	0.00145	0.00494	CcSEcCtD
Maprotiline—Nervous system disorder—Thalidomide—leprosy	0.00144	0.00492	CcSEcCtD
Maprotiline—Thrombocytopenia—Thalidomide—leprosy	0.00144	0.00491	CcSEcCtD
Maprotiline—Tachycardia—Thalidomide—leprosy	0.00144	0.0049	CcSEcCtD
Maprotiline—Skin disorder—Thalidomide—leprosy	0.00143	0.00487	CcSEcCtD
Maprotiline—Hyperhidrosis—Thalidomide—leprosy	0.00142	0.00485	CcSEcCtD
Maprotiline—Hypotension—Thalidomide—leprosy	0.00138	0.00469	CcSEcCtD
Maprotiline—Insomnia—Thalidomide—leprosy	0.00133	0.00454	CcSEcCtD
Maprotiline—Paraesthesia—Thalidomide—leprosy	0.00132	0.00451	CcSEcCtD
Maprotiline—Somnolence—Thalidomide—leprosy	0.00131	0.00446	CcSEcCtD
Maprotiline—Dyspepsia—Thalidomide—leprosy	0.0013	0.00442	CcSEcCtD
Maprotiline—HTR2A—tendon—leprosy	0.00127	0.00587	CbGeAlD
Maprotiline—Gastrointestinal disorder—Thalidomide—leprosy	0.00127	0.00433	CcSEcCtD
Maprotiline—Fatigue—Thalidomide—leprosy	0.00127	0.00433	CcSEcCtD
Maprotiline—HRH1—testis—leprosy	0.00126	0.00582	CbGeAlD
Maprotiline—Constipation—Thalidomide—leprosy	0.00126	0.00429	CcSEcCtD
Maprotiline—HRH1—nervous system—leprosy	0.00124	0.00571	CbGeAlD
Maprotiline—Feeling abnormal—Thalidomide—leprosy	0.00121	0.00414	CcSEcCtD
Maprotiline—Gastrointestinal pain—Thalidomide—leprosy	0.0012	0.0041	CcSEcCtD
Maprotiline—Urticaria—Thalidomide—leprosy	0.00117	0.00399	CcSEcCtD
Maprotiline—Abdominal pain—Thalidomide—leprosy	0.00116	0.00397	CcSEcCtD
Maprotiline—Body temperature increased—Thalidomide—leprosy	0.00116	0.00397	CcSEcCtD
Maprotiline—Asthenia—Thalidomide—leprosy	0.00106	0.0036	CcSEcCtD
Maprotiline—HTR2A—testis—leprosy	0.00105	0.00486	CbGeAlD
Maprotiline—Pruritus—Thalidomide—leprosy	0.00104	0.00355	CcSEcCtD
Maprotiline—HTR2A—nervous system—leprosy	0.00103	0.00477	CbGeAlD
Maprotiline—Diarrhoea—Thalidomide—leprosy	0.00101	0.00343	CcSEcCtD
Maprotiline—Dizziness—Thalidomide—leprosy	0.000974	0.00332	CcSEcCtD
Maprotiline—CYP2D6—testis—leprosy	0.000959	0.00443	CbGeAlD
Maprotiline—CYP2D6—nervous system—leprosy	0.000942	0.00435	CbGeAlD
Maprotiline—Vomiting—Thalidomide—leprosy	0.000937	0.00319	CcSEcCtD
Maprotiline—Rash—Thalidomide—leprosy	0.000929	0.00316	CcSEcCtD
Maprotiline—Dermatitis—Thalidomide—leprosy	0.000928	0.00316	CcSEcCtD
Maprotiline—Headache—Thalidomide—leprosy	0.000923	0.00314	CcSEcCtD
Maprotiline—Nausea—Thalidomide—leprosy	0.000875	0.00298	CcSEcCtD
Maprotiline—ABCB1—testis—leprosy	0.00069	0.00319	CbGeAlD
Maprotiline—ABCB1—nervous system—leprosy	0.000677	0.00313	CbGeAlD
